LumineticsCore® is highlighted in an American Academy of Ophthalmology (AAO) article about AI-powered solutions expanding access to diabetic retinopathy exams by bringing high-quality diagnostics into primary care.
In the article, Digital Diagnostics’ Founder and Executive Chairman Michael D. Abramoff, MD, PhD, notes:
“The point is, these autonomous AI systems are always meant to be where the eye specialist cannot be, but where the patient is.”